Completed OBSERVATIONAL NCT01446705

Evaluation of VLER-Indiana Health Information Exchange Demonstration Project (VLER-IHIE)

Evaluation of VLER_Indiana Health Information Exchange Demonstration Project

Sponsor: Regenstrief Institute, Inc.

Conditions Asthma Cardiovascular Diseases Diabetes Mellitus Heart Failure Osteoporosis

Interventions Active Health Information Exchange Non-Active Health Information exchange

Updated 9 times since 2017 Last updated: May 14, 2019 Started: Dec 31, 2012 Primary completion: Jun 30, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Asthma and Cardiovascular Diseases and is currently completed. Regenstrief Institute, Inc. leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2019 — Jan 2021 [monthly]

Completed
Jun 2018 — Jun 2019 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regenstrief Institute, Inc.
VA Office of Research and Development

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States